Tatva Chintan Pharma Chem, Chemplast Sanmar get SEBI go ahead to raise Rs 3950 crore IPOs


Source: medicaldialogues.in medicaldialogues.in

Key Topics in this News Article:

News Snapshot:

Tatva Chintan Pharma Chem, Chemplast Sanmar get SEBI go ahead to raise Rs 3950 crore IPOs By ruchikaPublished On 2021-07-07T13:53:47+05:30 | Updated On 7 July 2021 8:23 AM GMTNew Delhi: Chemplast Sanmar and Tatva Chintan Pharma Chem have received capital markets regulator Sebi's go ahead to raise Rs 3,950 crore collectively through initial share sales. Chennai-based Chemplast Sanmar filed preliminary IPO papers in May to raise Rs 3,500 crore, while specialty chemical manufacturing company Tatva Chintan Pharma Chem approached Sebi with its draft papers in April to garner Rs 450 crore through its initial public offering (IPO).Chemplast Sanmar and Tatva...